NEW YORK, Sept. 27 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb
(NYSE: BMY) announced today that Dr. Jeremy Levin has joined the company's
Research and Development organization as senior vice president, External
Science, Technology and Licensing. He will report to Dr. Elliott Sigal,
chief scientific officer and president, Research and Development.
"I am delighted Jeremy has joined our R&D organization at this critical
juncture for Bristol-Myers Squibb, as we look to further build our robust
pipeline in areas of significant unmet medical need and to transform our
pharmaceutical business for the future," said Dr. Sigal. "Jeremy's
extensive global network in the pharmaceutical, biotechnology and venture
industries will help ensure that we remain a leader in forging creative
partnerships to advance the development of novel medicines."
Prior to joining Bristol-Myers Squibb, Dr. Levin served as Global Head
of Business Development and Strategic Alliances at the Novartis Institutes
of Biomedical Research. In that capacity, he and his team secured hundreds
of collaborations in more than 20 countries since 2003. Prior to his tenure
at Novartis, Dr. Levin held leadership positions in several biotechnology
companies, including Physiome Sciences, Inc. and Cadus Pharmaceutical
Corporation. He also was managing director of Perseus Capital LLC, a life
sciences venture fund. He has served on the executive committees and boards
of several public biosciences companies, as well as the Executive Committee
of BIO and the boards of the Biotechnology Institute and the New York
Biotechnology Association.
"I am excited about the tremendous opportunity at Bristol-Myers
Squibb," said Dr. Levin. "I am especially looking forward to working with
Elliott, his team and all the outstanding people at this company. I will
look to aggressively complement Bristol-Myers Squibb's world class internal
team, capabilities and pipeline with the best science and medicines around
the globe."
Dr. Levin received a B.A. (First Class Honors) in Zoology, and M.A. and
Doctorate (D.Phil.) in Cell Biology and Chromatin Structure from the
University of Oxford, as well as a Medical Degree (MB BChir) from the
University of Cambridge. He practiced as a physician in internal medicine
in several university hospitals, including Hammersmith Hospital in London.
In 2005, Dr. Levin was awarded the Albert Einstein Award for Outstanding
Achievement in the Life Sciences.
Bristol-Myers Squibb is a global pharmaceutical and related healthcare
products company whose mission is to extend and enhance human life.
SOURCE Bristol-Myers Squibb
 back to top
Related links:
http://www.bms.com
CONTACT:
Media, Tony Plohoros, Communications,
+1-212-546-4379, tony.plohoros@bms.com, or Investors, John
Elicker, Investor Relations, +1-212-546-3775,
john.elicker@bms.com, both of Bristol-Myers Squibb
|
